Nano-engineered treatments
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
50
NCT03502148
Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jun 19, 2018
Completion: May 6, 2020
NCT05893888
Safety and Efficacy Study of PRV111 and PRV211 in Subjects With Oral Squamous Cell Carcinoma
Phase: Phase 2/3
Start: Nov 7, 2024
Completion: May 31, 2027
Loading map...